FNYS
ANGO icon

First New York Securities’s AngioDynamics ANGO Stock Holding History

First New York Securities’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,000
Closed -$16K – 199
2014
Q1 		$16K Buy
+1,000
New +$16.3K 0.01% 314

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First New York Securities's ANGO Position: Q2 2014 in Review

First New York Securities sold out of AngioDynamics (ANGO) in Q2 2014, closing a stake of 1,000 shares — an estimated $16K sold.

First New York Securities first reported a position in ANGO in Q1 2014 and held it in 1 quarter. The position peaked at $16K in Q1 2014. 109 funds tracked by Wall St. Rank hold ANGO as of Q2 2014.

  • First New York Securities reported no remaining AngioDynamics position as of Q2 2014 after selling out during the quarter.
  • First New York Securities sold 1,000 AngioDynamics shares in Q2 2014, an estimated $16K.
  • First New York Securities first reported a position in AngioDynamics in Q1 2014 and held it in 1 quarter.
  • First New York Securities's AngioDynamics position peaked at $16K in Q1 2014.
  • 109 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2014.

Based on First New York Securities's 13F filing for Q2 2014, filed 15 Aug 2014.